(2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide

C58H99N13O13 — CID 157091744

IUPAC(2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide
SMILESCC(C)CCCCC(=O)C[C@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)NC1CCNC(=O)[C@@H]([C@H](C)O)CC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)CC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O
InChIInChI=1S/C58H99N13O13/c1-33(2)12-10-11-15-40(74)30-38(16-22-59)51(77)71-50(36(6)73)58(84)69-45(20-26-63)55(81)68-46-21-27-64-53(79)41(35(5)72)32-49(76)42(17-23-60)65-54(80)43(18-24-61)66-52(78)39(28-34(3)4)31-48(75)47(29-37-13-8-7-9-14-37)70-56(82)44(19-25-62)67-57(46)83/h7-9,13-14,33-36,38-39,41-47,50,72-73H,10-12,15-32,59-63H2,1-6H3,(H,64,79)(H,65,80)(H,66,78)(H,67,83)(H,68,81)(H,69,84)(H,70,82)(H,71,77)/t35-,36+,38-,39+,41+,42-,43-,44+,45-,46?,47+,50-/m0/s1
InChIKeyKXMPOEKFPNVQSB-IKVUTWGJSA-N
MW1186.51 g/mol
LogP-2.36
Rot. Bonds29

About (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide

(2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide (PubChem CID 157091744) has the molecular formula C58H99N13O13 and a molecular weight of 1186.51 g/mol. Its IUPAC name is (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide.

Molecular Properties

Compound Name(2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide
PubChem CID157091744
Molecular FormulaC58H99N13O13
Molecular Weight1186.51 g/mol
Exact Mass1185.75
IUPAC Name(2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide
SMILESCC(C)CCCCC(=O)C[C@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)NC1CCNC(=O)[C@@H]([C@H](C)O)CC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)CC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O
InChIInChI=1S/C58H99N13O13/c1-33(2)12-10-11-15-40(74)30-38(16-22-59)51(77)71-50(36(6)73)58(84)69-45(20-26-63)55(81)68-46-21-27-64-53(79)41(35(5)72)32-49(76)42(17-23-60)65-54(80)43(18-24-61)66-52(78)39(28-34(3)4)31-48(75)47(29-37-13-8-7-9-14-37)70-56(82)44(19-25-62)67-57(46)83/h7-9,13-14,33-36,38-39,41-47,50,72-73H,10-12,15-32,59-63H2,1-6H3,(H,64,79)(H,65,80)(H,66,78)(H,67,83)(H,68,81)(H,69,84)(H,70,82)(H,71,77)/t35-,36+,38-,39+,41+,42-,43-,44+,45-,46?,47+,50-/m0/s1
InChIKeyKXMPOEKFPNVQSB-IKVUTWGJSA-N
XLogP-2.36
TPSA454.57 Ų
H-Bond Donors15
H-Bond Acceptors18
Rotatable Bonds29
Heavy Atoms84
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001186.51
LogP ≤ 5-2.36
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide?
The IUPAC name of (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide (CID 157091744) is (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide.
What is the SMILES notation for (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide?
The canonical SMILES for (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide is CC(C)CCCCC(=O)C[C@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)NC1CCNC(=O)[C@@H]([C@H](C)O)CC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)CC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.
What is the InChIKey of (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide?
The InChIKey is KXMPOEKFPNVQSB-IKVUTWGJSA-N. The full InChI is InChI=1S/C58H99N13O13/c1-33(2)12-10-11-15-40(74)30-38(16-22-59)51(77)71-50(36(6)73)58(84)69-45(20-26-63)55(81)68-46-21-27-64-53(79)41(35(5)72)32-49(76)42(17-23-60)65-54(80)43(18-24-61)66-52(78)39(28-34(3)4)31-48(75)47(29-37-13-8-7-9-14-37)70-56(82)44(19-25-62)67-57(46)83/h7-9,13-14,33-36,38-39,41-47,50,72-73H,10-12,15-32,59-63H2,1-6H3,(H,64,79)(H,65,80)(H,66,78)(H,67,83)(H,68,81)(H,69,84)(H,70,82)(H,71,77)/t35-,36+,38-,39+,41+,42-,43-,44+,45-,46?,47+,50-/m0/s1.
What are the key properties of (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide?
(2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide has a molecular weight of 1186.51 g/mol, XLogP of -2.36, 29 rotatable bonds, 15 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-(2-aminoethyl)-N-[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3R,11R,14S,17S,20R,23R)-3,14,17-tris(2-aminoethyl)-23-benzyl-11-[(1S)-1-hydroxyethyl]-20-(2-methylpropyl)-2,5,10,13,16,19,22-heptaoxo-1,4,9,15,18-pentazacyclotricos-6-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]-9-methyl-4-oxodecanamide is sourced from PubChem (CID 157091744), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).